Abiraterone Mylan Den europeiske union - slovakisk - EMA (European Medicines Agency)

abiraterone mylan

mylan ireland limited - abiraterón acetátu - prostatické nádory - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Abiraterone Krka Den europeiske union - slovakisk - EMA (European Medicines Agency)

abiraterone krka

krka, d.d., novo mesto - abiraterón acetátu - prostatické nádory - endokrinná terapia - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.

Abiraterone Accord Den europeiske union - slovakisk - EMA (European Medicines Agency)

abiraterone accord

accord healthcare s.l.u. - abiraterón acetátu - prostatické nádory - endokrinná terapia - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Akeega Den europeiske union - slovakisk - EMA (European Medicines Agency)

akeega

janssen-cilag international n.v. - abiraterone acetate, niraparib tosilate monohydrate - prostatic neoplasms, kastrácia-odolný - antineoplastické činidlá - treatment of adult patients with prostate cancer.

Abiraterone Glenmark 500 mg Slovakia - slovakisk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

abiraterone glenmark 500 mg

glenmark pharmaceuticals s.r.o., Česká republika - abiraterón - 44 - cytostatica

Abiraterone Glenmark 250 mg Slovakia - slovakisk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

abiraterone glenmark 250 mg

glenmark pharmaceuticals s.r.o., Česká republika - abiraterón - 44 - cytostatica

Abiraterone medac 500 mg filmom obalené tablety Slovakia - slovakisk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

abiraterone medac 500 mg filmom obalené tablety

medac gesellschaft für klinische spezialpräparate m.b.h., nemecko - abirateron - 44 - cytostatica

Abiraterone medac 250 mg tablety Slovakia - slovakisk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

abiraterone medac 250 mg tablety

medac gesellschaft für klinische spezialpräparate m.b.h., nemecko - abirateron - 44 - cytostatica